# STA-4783 and Paclitaxel for Treatment of Solid Tumors

> **NCT00088114** · PHASE1 · COMPLETED · sponsor: **Synta Pharmaceuticals Corp.** · enrollment: 50 (—)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** STA-4783/paclitaxel

## Key facts

- **NCT ID:** NCT00088114
- **Lead sponsor:** Synta Pharmaceuticals Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 50 (—)
- **Last updated:** 2014-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00088114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00088114, "STA-4783 and Paclitaxel for Treatment of Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00088114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*